Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Beckman Coulter Use InterSystems Ensemble Integration Platform

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
New solution eliminates manual booking of laboratory samples.

InterSystems has announced that Beckman Coulter is using InterSystems Ensemble® to improve the way samples are processed in hospital laboratories around the UK.

Ensemble is a platform for the rapid integration and development of connectable applications.

The new Automated Sample Receipting (ASR) solution was developed in less than six months and enables an end-to-end pathology service that is significantly more streamlined than current manual processes.

Early in 2012, in the pursuit of the highest quality balanced with cost efficiency in laboratory services, Beckman Coulter decided to create functionality within one of its sample processing systems that would eliminate the manual booking of samples.

Following a review of several options including using its own technology, Beckman Coulter chose Ensemble to integrate the target data management systems with hospital laboratory information systems and order communications systems.

As a result, samples can now be automatically recorded rather than requiring staff to scan individual sample barcodes manually.

Leanne Annereau, Marketing Manager at Beckman Coulter, said, “We are delighted to have partnered with InterSystems. We have been impressed by their collaborative approach, and the speed at which Ensemble enabled us to complete our product development - in less than six months from concept to delivery. From the start, we felt InterSystems had the right product and experience to make the project a success. We are now looking at other ways we can work together.”

The ASR solution service provides a number of distinct benefits to hospitals and clinicians. By reducing labour-intensive steps within laboratory processes, Beckman Coulter estimate a single laboratory can now process about 3,000 tubes daily, which translates into significant time and cost savings over manual processes.

In addition, the solution will improve the quality of results, since a significant proportion of pathology errors are related to the mishandling of samples or mismatching of patient information.

Jonathan Selby, Country Manager UK & Ireland at InterSystems, said, “We have built a strong partnership in a short time, and we are excited by the prospect of continuing our work supporting Beckman Coulter in their development of breakthrough solutions that simplify processes, improve accuracy, and reduce costs in biomedical testing.”

Beckman Coulter estimates that the first pilot sites will be operational before the end of the year.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos